Samsung Partners With Decentralized AI Healthcare Protocol Galeon

Tech behemoth Samsung has partnered with decentralized science (DeSci) and healthcare artificial intelligence protocol Galeon to provide AI training data from its ultrasound devices.

According to a Tuesday announcement shared with Cointelegraph, Samsung said it will integrate its ultrasound equipment with Galeon’s electronic health record (EHR) platform. Speaking to Cointelegraph, Galeon CEO Loïc Brotons said the EHR is already live in 18 interconnected hospitals, including those in France at Rouen University Hospital, Caen University Hospital, Toulon Hospital and Sud Francilien Hospital.

Samsung and Galeon said the effort aims to improve medical data availability while keeping a privacy-first approach. Brotons said the data itself is not stored onchain; only the AI algorithm operates onchain “with full traceability of how the algorithm is operating.” He added that all data is anonymized before training for privacy compliance reasons.

The collaboration allows healthcare providers to train AI models without centralizing patient information. Each hospital or institution retains control over its data while benefiting from shared algorithm training.

Related: Blockchain and AI can enable advanced personalization in healthcare

Decentralized science takes on medicine

Healthcare has emerged as one of the most active sectors in decentralized science. Alex Dobrin, awareness steward at VitaDAO — a decentralized collective working to extend human lifespans — told Cointelegraph that the time and cost requirements of drug development motivate people to take matters into their own hands.

In May, DeSci decentralized autonomous organization HydraDAO claimed that one of its research projects resulted in “rats who had their spines fully transected” being able to walk again in five days. Such news appears to be prompting investors to take notice.

Related: Decentralized science meets AI — legacy institutions aren’t ready

Investors show interest in DeSci

DeSci platform Bio Protocol secured backing from investors, including Maelstrom Fund and Animoca Brands, in a $6.9 million funding round earlier this month. This followed the company’s investment from Binance Labs, the cryptocurrency exchange’s venture capital arm, at the end of 2024.

Data is at the center of many of those projects, with DeSci platforms now fighting to acquire genetic data from bankrupt DNA testing service 23andMe.